Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

192.24
Delayed Data
As of Jul 31
 +1.86 / +0.98%
Today’s Change
131.69
Today|||52-Week Range
194.73
+17.41%
Year-to-Date

Today’s Trading

Previous close190.38
Today’s open192.48
Day’s range190.34 - 194.73
Volume392,153
Average volume (3 months)441,501
Market cap$11.8B
Dividend yield--
Data as of 4:14pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-73.50%
Earnings growth (this year)+14.67%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+34.44%
P/E ratio55.2
Price/Sales8.74
Price/Book8.54

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+2.49+3.69%
RDYDr.Reddy's Laborator...+2.35+3.79%
MNKMallinckrodt Plc+2.26+1.86%
MDVNMedivation Inc+8.36+8.62%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$2.41
Annual revenue (last year)$1.2B
Annual profit (last year)$58.4M
Net profit margin4.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts